Latest Security News

Firebird Metals is developing Lithium Manganese Rich cathode materials to target next-generation solid-state batteries, aiming to strengthen its position in the evolving EV and high-energy battery markets.

Acrux Limited reports promising revenue growth driven by new topical generic launches in the US and secures crucial RDTI funding, marking a strategic shift under new CEO John Warmbrunn.

Ionic Rare Earths’ Belfast plant is ramping up production of critical heavy rare earth oxides to meet soaring demand from Western markets following China’s export restrictions. This strategic move positions the company as a key supplier for defence, renewables, and advanced manufacturing sectors.

Lakes Blue Energy has secured $6.5 million in new capital and is set to begin drilling the Wombat-5 gas well, targeting near-term supply to Victoria’s east coast market. Meanwhile, its Nangwarry carbon dioxide project moves forward with a fully funded feasibility study.

Solis Minerals has kicked off diamond drilling at its Chancho al Palo copper-gold project in Peru, revealing promising visual mineralisation including visible gold, while advancing permits and funding to support further exploration.

Great Northern Minerals advances the sale of a majority stake in Golden Ant Mining, securing a $1 million payment upon final phase completion, while maintaining a $1.29 million cash balance and exploring new resource opportunities.

Future Metals NL has raised A$4.2 million and entered a strategic MOU with Zeta Resources to explore processing its Eileen Bore and Panton ores at the Savannah Mine plant, signalling a new phase of development amid rising PGM prices.

AusQuest Limited reports significant expansion of its copper-gold system at the Cangallo Project in Peru, alongside progress across multiple Australian base metal projects, supported by a solid cash position and strategic funding.

Felix Gold is advancing its Treasure Creek Project in Alaska, aiming for the first domestic antimony concentrate production in over 30 years by late 2025 or early 2026, supported by strong government engagement and solid finances.

Actinogen Medical has reached a key milestone in its XanaMIA phase 2b/3 Alzheimer’s trial with over 100 participants enrolled, setting the stage for an interim analysis in January 2026. The company also secured a $13.8 million non-dilutive R&D funding facility to support ongoing development.

Jade Gas Holdings has secured a A$3.64 million director loan to advance production at its Red Lake Gas Field, anticipating a transformational gas breakthrough this quarter.

Locate Technologies reported a 5% revenue increase for FY25, driven by strong growth in its Locate2u platform, while Zoom2u faced revenue headwinds. The company also expanded its Bitcoin holdings and raised $2.5 million in capital.